CytomX Therapeutics Inc (CTMX) — Tangible Net Worth Ratio
CytomX Therapeutics Inc (CTMX) has a Tangible Net Worth Ratio of 99.9% as of March 2026. This metric is calculated by deducting intangible assets ($401.00K) from net assets ($319.94 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See CTMX working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
CytomX Therapeutics Inc Tangible Net Worth Ratio (2015–2025)
This chart shows how CytomX Therapeutics Inc's Tangible Net Worth Ratio has changed across 7 annual periods from 2015 to 2025. As of March 2026, the ratio stands at 99.9%, reflecting net assets of $319.94 Million with intangible assets of $401.00K USD. See CTMX days of operational coverage to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for CytomX Therapeutics Inc (2015–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for CytomX Therapeutics Inc from 2015 to 2025, covering 7 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see CytomX Therapeutics Inc market capitalisation.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 99.6% | $99.01 Million | $438.00K | $151.57 Million | ▲ +0.7 pp |
| 2021 | 98.9% | $89.38 Million | $1.02 Million | $339.41 Million | ▲ +1.4 pp |
| 2019 | 97.4% | $51.11 Million | $1.31 Million | $341.28 Million | ▼ -1.5 pp |
| 2018 | 98.9% | $130.88 Million | $1.46 Million | $457.11 Million | ▲ +1.2 pp |
| 2017 | 97.7% | $69.90 Million | $1.60 Million | $397.64 Million | ▼ -0.1 pp |
| 2016 | 97.8% | $78.48 Million | $1.75 Million | $199.13 Million | ▼ -0.8 pp |
| 2015 | 98.6% | $126.07 Million | $1.75 Million | $197.22 Million | — |